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Abstract
Tuberculosis (TB) remains a major cause of morbidity and mortality worldwide. It is expected that combining multiple molecular methods
will further help in focusing contact investigations. We performed a population-based molecular epidemiological study in six sites in China
between 1 June 2009 and 31 December 2010. A genotyping method combining 7-loci MIRU-VNTR and IS6110-based RFLP was employed to
determine predictors of recent transmission. A second interview was performed with the clustered patients to identify potential
epidemiological links. The molecular clustering analysis revealed that 187 isolates (15.3%) were clustered by sharing identical VNTR-IS6110
combined patterns, with an estimated recent transmission index being 8.9%. None of these patients reported having contacts with other
members within the same cluster. Nineteen of 121 reported having a history of contact with a TB case within 2 years before the current TB
diagnosis. Additionally, geographical correlation was established for 19 cases in nine clusters, while only one possible epidemiological link
was established in secondary interview. The results underscore the role of casual contact or reactivation of latent TB as a driving factor
maintaining the current endemicity in rural China, with high disease burdens of tuberculosis.
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Tuberculosis (TB) remains a major cause of morbidity and
mortality worldwide. Particularly worrisome is the worldwide
emergence of multidrug-resistant (MDR) and extensively
resistant forms of Mycobacterium tuberculosis (Mtb) strains that
are difﬁcult to treat and associated with poor therapeutic
outcomes [1].
Globally in 2012, data from drug resistance surveys and
continuous surveillance among notiﬁed TB cases suggest that
3.6% of newly diagnosed TB cases and 20% of those previously
treated for TB had MDR-TB [2]. China has the second highest
burden of TB worldwide, with c. 1.3 million new TB cases
detected annually [3]. Additionally, China is one of the hot
spots of MDR-TB, with a prevalence of MDR-TB of 5.7% and
25.6% among new and previously treated cases according to
the latest national TB survey in 2008 [4].
Molecular tools have enhanced our understanding of TB
epidemiology by providing insight into the transmission dynam-
ics, source and spread of Mtb [5,6]. Moreover, molecular
epidemiological methods have reﬁned the estimates of recent
transmission so that they are important indicators in assessing
the effectiveness of TB control programmes [7,8] and identi-
fying previously unrecognized epidemiological links [9,10].
Conversely, genotyping has highlighted some limitations of
conventional contact investigations to identify recent trans-
mission. For instance, a molecular epidemiological study
suggested that interventions only for close contacts might be
inadequate to identify recently infected patients if contact
occurs outside the household or close relatives/friends [11]. In
Rotterdam, molecular typing identiﬁed widespread transmis-
sion from multiple sources among drug users, illustrating the
limitations of contact investigation in high-risk populations and
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prompting an active case-ﬁnding programme [12]. In various
settings, a substantial proportion of household contacts were
infected with a different strain to that of the index case: 30% in
California [13] and 54% in Cape Town [14]. The utility of
molecular methods in clarifying transmission patterns was
heavily dependent on the half-life of biomarker(s) used [15]. As
such, it is expected that combining multiple molecular methods
such as restriction fragment length polymorphisms (RFLP)
typing with biomarkers including mycobacterial interspersed
repetitive unit-variable number of tandem repeats (MIR-
U-VNTR) will further help in focusing contact investigations.
In the present work, we used MIRU-VNTR and
IS6110-based RFLP genotyping to understand the transmission
of TB in rural China by examining circulating M. tuberculosis
strains and to determine the predictors of recent transmission.
Materials and Methods
We performed a population-based molecular epidemiological
study at six sites inChina between 1 June 2009 and 31December
2010 (Fig. 1). The ﬁeld sites cover a total population of about
5.8 million inhabitants; 67% of them were part of a rural
population, including three counties (Changshan [CS], Tengz-
hou [TZ] and Shenxian [SX]) in Shandong Province and three
counties (Jianhu [JH], Guanyun [GY] and Ganyu [GYu]) in
Jiangsu Province.
Study population
Inclusion criteria were patients who had active TB that was
bacteriologically conﬁrmed by sputum culture and who
provided informed consent for this study. Extra-pulmonary
TB cases were excluded from the study. Ethical approval was
given by the Ethics Committee of the School of Public Health,
Fudan University.
Data collection
Subjects were interviewed at the time of TB diagnosis at the
county TB dispensaries (CTDs) by physicians who underwent
a 2-day training course for the interview. A semi-structured
questionnaire was developed that covered general demo-
graphic and socio-economic characteristics, clinical symptoms
and disease history at TB diagnosis. BCG vaccination was
determined by self-reporting and conﬁrmed by the presence of
a scar at interviewing. Family income was self-reported; the
products that families produced during the same time were
converted and added to the total income.
A second interview was performed only with clustered
patients to identify potential epidemiological links. Each of the
clustered patients was interviewed again to obtain more-de-
tailed data that were not recorded at the ﬁrst interview (e.g.
data regarding jobs, detailed migration/relocation information
before the onset of TB, entertainment activities and related
locations) and more information about known contacts with
TB. Finally, the patients were asked whether they could
recognize some or all of the patients clustered with them.
During the interview, we asked the participants to give their
oral consent to divulge their identity to other TB patients in
their cluster. When patients were absent or refused to come,
we telephoned the patients or their families to obtain their
permission for the disclosure of their identity.
Molecular characterization
The sputum samples of patients were sent to the reference
laboratory in the Shandong Provincial TB Center for culture
and drug susceptibility testing. Drug susceptibility testing was
performed for isoniazid, rifampin, pyrazinamide and ethambu-
tol on Lowenstein-Jensen solid medium. Drug-resistant TB
refers to TB that is resistant to any of the four ﬁrst-line
anti-tuberculosis drugs. MDR-TB is deﬁned as TB that is
resistant to at least isoniazid and rifampicin.
Mycobacterium tuberculosis genomic DNA was extracted in
the laboratory by standard methods [16] and then shipped to
Fudan University to genotype the M. tuberculosis isolates using
a high-resolution 7-loci variable number of tandem repeats
(7-VNTR) method that was described by Zhang et al. [17],
showing sufﬁcient discriminatory power to differentiate
prevalent W-Beijing genotype strains in the Chinese popula-
FIG. 1. Number of cases with different epidemiological contact
histories during the follow-ups.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 1140–1145
CMI Wang et al. Casual contact in TB transmission 1141
tion. Only one isolate per each patient was included in this
study. Isolates with identical 7-VNTR genotypes were sub-
jected to IS6110-based RFLP analysis. A combined cluster was
deﬁned as a series of isolates that had both the same VNTR
allele proﬁle and IS6110 ﬁngerprint identity.
Estimation of recent transmission
In order to estimate the extent of recent transmission of TB,
we calculated the widely used index RTIn1 = (nc  c)/n,
where n is the total number of cases in the sample, c is the
number of genotypes represented by at least two cases, and nc
is the total number of cases in a cluster of two or more [18].
Statistical analysis
The chi-squared test was used to assess differences in the
proportion of M. tuberculosis isolates clustering with different
genotypes; when the expected value was <5, Fisher’s exact
two-tailed test was used. Variables were examined both in
univariate analyses and the binary logistic model where the
odds ratio (OR) for the proportion clustering was adjusted for
age, sex and county. The family income was skewed, and the
variable was therefore included in the logistic regression
model after being separated into two groups by median.
Statistical analysis was carried out by SPSS software 11.0 (SPSS
Inc., Chicago, IL, USA).
Results
Subject characteristics
From January 2007 through to December 2008, a total of 2221
registered pulmonary TB patients were recruited in the local
TB dispensaries. After bacterial culture and strain identiﬁca-
tion, a total of 1546 VNTR patterns were successfully
obtained. Subsequently, 1222 VNTR-IS6110 combined DNA
ﬁngerprints were obtained and included in the analysis
(Table 1), including 275 (22.5%) in CS, 188 (15.4%) in TZ,
168 (13.7%) in SX, 150 (12.3%) in JH, 248 (20.3%) in GY and
193 (15.8%) in GYu. Another 40 isolates were non-tubercu-
losis Mycobacteria and two isolates were Mycobacterium bovis.
The patients ranged from 16.2 to 88.9 years old, with a
mean age of 48.4 years (Table 2).
Clustering and recent transmission
The 7-VNTR-based genotyping indicated that 324 isolates
(26.5%) shared identical VNTR-IS6110 patterns, which were
referred to as the ‘cluster’ category; the remaining 898 isolates
exhibited a unique pattern, and were referred to as unique
category/isolates. In addition, the molecular clustering analysis
combined 7-VNTR-based genotyping and IS6110-based RFLP
and revealed that 187 isolates (15.3%) were clustered. Of the
258 drug-resistant Mtb isolates, a total of 233 VNTR-IS6110
RFLP genotype patterns were observed, with 21 clusters
composed of 46 drug-resistant isolates (16.7%). The total
RTIn1 was estimated at 8.9%. Of these clusters, 18 clusters
were composed solely of 43 drug-resistant isolates, and the
other three clusters were shared among three drug-resistant
and three pan-susceptible isolates. The 20 MDR isolates
(25.6%) represented 12 VNTR-IS6110 RFLP proﬁles, and the
remaining 58 isolates exhibited unique genotypes, indicating a
10.3% RTIn1 (vs. non-MDR isolates, p 0.01).
Risk factors for recent transmission
To identify risk factors for recent infection with Mtb, patients
harbouring clustered isolates were compared with patients
whose isolates were not in clusters (Table 3). Univariate
analysis indicated that TB patients who worked out of town
(domestic migrant workers) during the 1 year prior to the
investigation had a signiﬁcantly higher rate of clustering than
those who did not (21 vs.14%; OR, 1.66; 95% CI, 1.17–2.37).
Patients infected with MDR Mtb were more likely to be
clustered than those with non-MDR isolates. After adjustment
TABLE 1. Odds ratio and adjusted odds ratio (and 95%
conﬁdence interval) for risk factors for clustering (cluster/
unique)
Clustered
Crude
OR (95% CI)a
Adjusted
OR (95% CI)bTotal No. %
Pulmonary cavities
No 789 116 14.7 1 1
Yes 427 70 16.4 1.14 (0.80–1.53) 1.05 (0.75–1.50)
TB history
Newly
diagnosed
1039 160 15.4 1 1
Previously
treated
183 27 14.8 0.95 (0.61–1.48) 0.85 (0.51–1.41)
Smear test
Negative 248 34 13.7 1 1
Positive 974 153 15.7 1.13 (0.76–1.67) 1.13 (0.75–1.71)
Work away from hometown
No or
missing
970 134 13.8 1 1
Yes 252 53 21.0 1.66 (1.17–2.37)‡ 1.35 (0.91–2.01)
Low-income householdc
No 59 7 11.9 1 1
Yes 1163 180 15.5 0.74 (0.53–1.03) 0.82 (0.57–1.16)
Report contact with tuberculosis patients at diagnosis
No 1213 183 15.1 1 1
Yes 8 1 12.5 0.79 (0.10–6.46) 0.81 (0.09–7.00)
MDR-TB
No 1144 167 14.6 1 1
Yes 78 20 25.6 2.02 (1.18–3.44)† 2.16 (1.18–3.95)†
BCG
No or
unknown
835 123 14.7 1 1
Yes 387 64 16.5 1.15 (0.83–1.60) 0.73 (0.47–1.15)
aEstimated from univariate logistic model.
bEstimated from multivariate logistic model, with adjustment for age and sex.
cLow-income household referred to those that were living below median income.
†p <0.05.
‡p <0.01.
MDR-TB, multidrug-resistant tuberculosis (resistant to at least isoniazid and
rifampicin); BCG, Bacillus Calmette-Guerin.
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for age and sex, MDR remained signiﬁcantly associated with
clustering (OR, 2.16; 95% CI, 1.18–3.95).
Epidemiological contacts and recent TB transmission
Of the 187 patient isolates in 70 clusters, 66 patients were lost
to follow-up due to no response to the telephone call or death
before the investigation. To determine epidemiological links,
face-to-face interviews were conducted with the remaining 121
patients. While none of these 121 patients with successful
follow-up reported having contacts with other members of the
same cluster, 19 reported having a history of contact with a TB
case who was not included in the current study cohort within
2 years before the current TB diagnosis. Additionally, geo-
graphical correlation was established for 19 cases in nine
clusters. Only one possible epidemiological link was established
in a deceased patient whose wife reported that the patient had
worked in the same factory as other patients within the cluster
(Table 2).
Discussion
We used a combination of molecular methods and epidemio-
logical data to determine the genetic diversity of circulatingMtb
strains, and provide the estimates of recent transmission and
risk factors for clustering among pulmonary TB patients in rural
TABLE 2. Contact information for the patients who had a history of contact with TB patients
Case No Cluster No Epi-link Contact information
CA8058 CA13 No Denied contact history with case in same cluster, but had contacts with other TB patients.
CA8134 CA13 No Denied contact history with case in same cluster, but her husband was a TB patient.
CA0102 CA3 No Denied contact history with case in same cluster, but had contacts with another TB patient.
CA0058 CA7 No Denied contact history with case in same cluster, but had contacts with other TB patients.
GA9035 GA10 No Denied contact history with case in same cluster, but had contacts with other TB patients.
GA8064 GA11 No Denied contact history with case in same cluster, but had contacts with other TB patients
(roommates) when working outside.
GA0071 GA14 No Denied contact history with case in same cluster, but had contacts with another
TB patient (a teacher).
GA0055 GA19 No Denied contact history with case in same cluster, but had contacts with other TB patients
(roommates), when working outside.
GA0009 GA2 No Denied contact history with case in same cluster, but had contacts with other
TB patients (neighbours).
GU9099 GU11 No Denied contact history with case in same cluster, but had contacts with other TB patients
(father and brothers).
GU0009 GU13 No Denied contact history with case in same cluster, but had contacts with other TB patients
when working as a computer repairman.
GU0003 GU14 No Denied contact history with case in same cluster, but had contacts with other TB patients
(father and roommates).
JI8076 JI2 Possible Died of TB; his wife reported having history of contacts with the case in same cluster.
JI8080 JI5 No Denied contact history with case in same cluster, but had contacts with another
TB patient (a friend).
JI9127 JI5 No Denied contact history with case in same cluster, but had contacts with another
TB patient (a colleague).
JI9016 JI8 No Denied contact history with case in same cluster, but had contacts with another TB patient
(his father, who died of TB).
JI8028 JI9 No Denied contact history with case in same cluster, but had contacts with other TB patients
(neighbours).
XI8067 XI1 No Denied contact history with case in same cluster, but had contacts with another TB patient
(a friend, who he also frequently played card games with).
XI0032 XI7 No Denied contact history with case in same cluster, but had contacts with other TB patients
(a neighbour, who was detected as having TB 4 months prior to this case, and his brother).
Epi-link, epidemiological links; TB, tuberculosis.
TABLE 3. Estimation of recent transmission among the isolations
Drug resistance
No. of
patients Proportion (%)
No. of patients
in the clustersa
No. of
clustersa Cluster sizea
Proportion
clusteringa (%) p value* RTIn1
b (%)
Total 1222 100.0 187 78 1–4 15.3 8.9
Pan-sensitive 964 78.9 141 55 1–4 14.6 0.143 8.9
Any drug (INH, IRF,
STR or EMB)
258 21.1 46 21 1–3 16.7 <0.001 9.7
INH 157 12.8 45 16 2–3 28.7 <0.001 18.5
RIF 98 8.0 20 13 1–2 20.4 0.143 7.1
STR 191 15.6 17 12 1–2 8.9 0.004 2.6
EMB 35 2.9 2 2 1–2 5.7 0.077 0.0
MDR-TB 78 6.4 20 12 1–2 25.6 0.010 10.3
aDetermined by a combined genotyping of IS6110 RFLP and 7-VNTR.
bEstimated proportions of recent transmission, RTIn1 = (nc  c)/n, where n is the total number of cases in the sample, c is the number of genotypes represented by at least two
cases, and nc is the total number of cases in cluster of size two or more [18].
*p value was obtained from the chi-square test.
INH, isoniazid; IRF, rifampin, STR, streptomycin; EMB, ethambutol.
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China, where on average 67% of the population belonged to an
agricultural population. A recent nationwide survey showed
that the prevalence of TB was relatively higher in rural areas
than in urban areas, which is not the case in low-incidence
countries [19]. The surprisingly low clustering found in this
study, in contrast to places such as South Africa, which has
co-infection of TB and human immunodeﬁciency virus (HIV) and
explosive outbreaks (i.e. large cluster sizes), suggests that casual
contact may be more important than previously thought.
In China, case ﬁnding for TB is mainly passive. Although
being a household contact of a TB patient is a strong risk factor
[20,21], in high-incidence settings most cases of TB are not
attributable to household contact [22]. Therefore the impor-
tance of casual contact in TB transmission is not surprising
because many people exposed to a small risk can account for
more cases than a few exposed to a large risk [23].
The total rate of clustering (15%), which is substantially lower
than estimates reported in other studies conducted in low-inci-
dence areas (e.g. Denmark (49%) [24], New York (48%) [25],
Spain (36%) [26], Germany (49%) [27], San Francisco (70%) [13]
and elsewhere in the United States (71%) [28]), is also lower
than most of the other reported ﬁgures in China, ranging from
10% to 32% [29–31]. Using the n1 method, 9% of cases were
likely to be due to recent transmission in this region. Although
inconsistent, studies increasingly report that MDR strains are
one of the risk factors for recent transmission [32], a notion
supported by our ﬁndings.
Traditional approaches have shown that certain groups are at
higher risk for TB (e.g. elderly people, prisoners, the homeless
and injecting drug users) andnon-traditional settingswhere these
groups congregate are important in facilitating TB transmission
[33]. In contrast to those ﬁndings, contactswithin andoutside the
family and household were less likely to be conﬁrmed as sources
of infection [28]. Moreover, no place or occasion could be
conﬁrmed as the source or geographical point of transmission,
even in sites that had a relatively enclosed population.
Mtb genotyping techniques offer a method for TB prevention
and control [34] by demonstrating previously unrecognized
linkages even within endemic communities. The ability of Mtb
genotyping to estimate recent TB transmission, however, has
been both asserted and challenged [10]. In the current study, we
found that 27% of the isolates shared 7-VNTR ﬁngerprint
patterns; when the IS6110 was combined, however, it became
15%. The combination of 7-VNTR and RFLP increased the
Hunter-Gaston discriminatory index and therefore decreased
the proportion of cases attributed to recent transmission. A
previous study indicated that the HGI value of 7-VNTR was
slightly lower than that of IS6110 RFLP genotyping in China, thus
requiring secondary genotyping of clustered strains (e.g. IS6110
RFLP) to efﬁciently differentiate Beijing genotype strains [17].
This study identiﬁed small cluster sizes ranging from two to
four patients, indicating limited scale of transmission in this
high-incidence rural area. Low clustering rates combined with
small cluster sizes may indicate a more vital role of reactive
disease compared with recent transmission. The disparities in
the scale of clustering between countries with a high and low TB
disease burden appear obvious [35]. However, the mechanisms
to explain the difference are complex. Unlike in other
high-incidence countries, where TB patients in urban areas
were more likely to be clustered [36], those patients in a rural
setting in China were subjected to a higher risk of clustering.
This disparity may be partly driven by the frequent population
movement in China’s urban areas [37], and therefore it is usually
difﬁcult to obtain an entire proﬁle of TB transmission.
Patients for this study were those who registered in the
CTDs; this sample represented about 80% of the patients in
the studied communities according to the estimates from a
recent household screening study during the same period [38].
Therefore, some potential source cases may have been missed
in those communities, thereby underestimating the actual
extent of recent transmission. Lastly, although the 7-VNTR
genotyping method was reported to be less discriminating
relative to IS6110 RFLP for isolates predominating in China,
the combined genotyping method employed in this study may
have still underestimated the rate of clustering.
Conclusion
In conclusion, in rural China, where remote reactivated TB is
the main concern as indicated by the low rate of clustering, few
epidemiological links could be established among those in
molecular clusters, underscoring the role of casual contacts or
reactivation of latent TB as a driving factor maintaining the
current endemicity in China. This suggests the need for
prevention strategies (e.g. isoniazid preventive therapy) to
reduce active TB in people with latent TB infection, which has
also been proposed by the World Health Organization [39].
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